Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents.
about
Vascular and plaque imaging with ultrasmall superparamagnetic particles of iron oxideNanoparticles in magnetic resonance imaging: from simple to dual contrast agentsBlock copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticlesIron nanoparticles increase 7-ketocholesterol-induced cell death, inflammation, and oxidation on murine cardiac HL1-NB cells.Enhanced MRI T 2 Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles.Multifunctional materials for bone cancer treatment.Surface functionalization of magnetic iron oxide nanoparticles for MRI applications - effect of anchoring group and ligand exchange protocol.A new nano-sized iron oxide particle with high sensitivity for cellular magnetic resonance imagingEnhanced magnetic resonance imaging and staining of cancer cells using ferrimagnetic H-ferritin nanoparticles with increasing core size.Evaluation of brain tumor vessels specific contrast agents for glioblastoma imagingUltrasmall superparamagnetic iron oxide (USPIO)-based liposomes as magnetic resonance imaging probes.A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancerIn vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesCertain types of iron oxide nanoparticles are not suited to passively target inflammatory cells that infiltrate the brain in response to strokeEssential Elements to Consider for MRI Cell Tracking Studies with Iron Oxide-based Labeling AgentsAptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells.Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.Magnetite Nanoparticles for Medical MR Imaging.Molecular characterization of rheumatoid arthritis with magnetic resonance imaging.Current Status and Future Direction of Nanomedicine: Focus on Advanced Biological and Medical Applications.pH-Sensitive O6-Benzylguanosine Polymer Modified Magnetic Nanoparticles for Treatment of Glioblastomas.Experimental bladder regeneration using a poly-l-lactide/silk fibroin scaffold seeded with nanoparticle-labeled allogenic bone marrow stromal cells.Tuning the growth pattern in 2D confinement regime of Sm2O3 and the emerging room temperature unusual superparamagnetism.Impact of surface coating and particle size on the uptake of small and ultrasmall superparamagnetic iron oxide nanoparticles by macrophagesApplication of nanoparticles on diagnosis and therapy in gliomas.Phosphonic acid: preparation and applications.Detection of MUC1-expressing ovarian cancer by C595 monoclonal antibody-conjugated SPIONs using MR imaging.Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of NanoparticlesA GPC3-specific aptamer-mediated magnetic resonance probe for hepatocellular carcinoma
P2860
Q26783581-1E7C5A88-120D-4B42-8DAA-7C656700AB10Q28082690-3BEE7E51-E03A-4C5F-AA33-D0AD34FFC8E2Q30574016-4A606493-80CD-4165-8CB6-26CB145ABE4FQ33576888-5F72BD0D-7DEB-4999-B5D5-EDAD9D7F60E2Q33609943-1EE834D3-CDE3-4BEF-B950-D27F9BD46ABEQ33709363-749E2B0B-7D01-4FA1-AEBA-825C9FE206A9Q34001011-BAC9DFDA-5E0C-429F-ADDF-A05D903B2239Q34927786-3C6F5D52-EECC-41E5-AFDC-7660E1F14FF0Q35298245-EAB73C1A-A3FE-4F56-B212-3D95D8993A8EQ35633826-8038F9E4-5CBD-46E1-ACE2-7F76BF17D860Q35979160-B70BE14A-685D-4BBE-82E2-1821BB5BD9D8Q36255138-E95A1C2A-B3E4-4434-AEBE-A2D843D0DF73Q36289257-D17C6D69-9CF4-46C6-B404-B5830413AA84Q36839949-9DDBB9B1-3C9A-4944-95F7-FB01BED0B4FBQ37246904-D90ABDD3-FC51-471D-BC36-79977B526A88Q37504779-FF8E199C-A526-4A41-878D-0AD7FF7956F9Q37631874-6B823D8B-019B-4BC8-915D-CF06191790B7Q37990502-0F2415FD-AF17-49D3-BCEB-871DB6AF0CCCQ38014684-06A8A1B2-4180-4BCA-B9ED-DA8AC4F9EA19Q38676959-02586C9B-E6F2-4267-BA61-4A371726F2C0Q38726887-5F184432-D3A8-4881-90A0-DC770018A6CAQ41066373-F3FC3196-26CB-4BBE-80D8-7E088A465CB0Q42126699-DCC0985C-F2D7-4329-99BD-0AC00E94F047Q42417127-0CB0F357-5F4F-4968-878A-73902FCE7725Q43165459-83B5958B-AD9B-4870-AE5B-0FABF591E20EQ47165356-D024C879-A72B-461D-A67E-A03AF798C358Q51773840-D10CCA25-EC9C-4300-AA0B-D1B4ED77E09BQ57181636-AFC21BF5-ABA9-4555-B382-09D216E0AD4DQ57181708-5894573A-58FC-4FA0-AD7F-5E02F63A2812
P2860
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Physicochemical characterizati ...... cation as MRI contrast agents.
@en
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles
@nl
type
label
Physicochemical characterizati ...... cation as MRI contrast agents.
@en
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles
@nl
prefLabel
Physicochemical characterizati ...... cation as MRI contrast agents.
@en
Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles
@nl
P2093
P2860
P1476
Physicochemical characterizati ...... ication as MRI contrast agents
@en
P2093
Catherine Dubernet
Claudia Sadun
Irene Guilbert
Mariagrazia Di Marco
Patrick Couvreur
P2860
P304
P407
P577
2007-01-01T00:00:00Z